Neutralizing antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are being developed world over. We investigated the possibility of producing artificial antibodies from the formalin fixation and paraffin-embedding (FFPE) lung lobes of a patient who died by coronavirus disease 2019 (COVID-19). The B-cell receptors repertoire in the lung tissue where SARS-CoV-2 was detected were considered to have highly sensitive virus-neutralizing activity, and artificial antibodies were produced by combining the most frequently detected heavy and light chains. Some neutralizing effects against the SARS-CoV-2 were observed, and mixing two different artificial antibodies had a higher tendency to suppress the virus. The neutral...
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends ...
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends ...
Patients who recover from SARS-CoV-2 infections produce antibodies and antigen-specific T cells agai...
Neutralizing antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are...
The B cell-mediated humoral immune response is a major part of the human immune system and shapes di...
Summary: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages that...
The interactions between antibodies, SARS-CoV-2 and immune cells contribute to the pathogenesis of C...
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends ...
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends ...
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends ...
COVID-19, caused by SARS-CoV-2, has rapidly spread to more than 160 countries worldwide since 2020. ...
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends ...
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends ...
Passive immunization using monoclonal antibodies will play a vital role in the fight against COVID-1...
Passive serotherapy can confer immediate protection against microbial infection, but methods to rapi...
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends ...
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends ...
Patients who recover from SARS-CoV-2 infections produce antibodies and antigen-specific T cells agai...
Neutralizing antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are...
The B cell-mediated humoral immune response is a major part of the human immune system and shapes di...
Summary: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages that...
The interactions between antibodies, SARS-CoV-2 and immune cells contribute to the pathogenesis of C...
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends ...
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends ...
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends ...
COVID-19, caused by SARS-CoV-2, has rapidly spread to more than 160 countries worldwide since 2020. ...
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends ...
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends ...
Passive immunization using monoclonal antibodies will play a vital role in the fight against COVID-1...
Passive serotherapy can confer immediate protection against microbial infection, but methods to rapi...
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends ...
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends ...
Patients who recover from SARS-CoV-2 infections produce antibodies and antigen-specific T cells agai...